Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Brulamycin
2. Nebcin
3. Nebicin
4. Nebramycin Factor 6
5. Obracin
6. Sulfate, Tobramycin
7. Tobracin
8. Tobramycin
1. 49842-07-1
2. Tobramycin Sulphate
3. Nebcin
4. Tobramycinsulfate
5. 79645-27-5
6. Mls000069826
7. Smr000058891
8. Dartobcin
9. Nebcine
10. Tobraneg
11. Tobrasix
12. (2s,3r,4s,5s,6r)-4-amino-2-{[(1s,2s,3r,4s,6r)-4,6-diamino-3-{[(2r,3r,5s,6r)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol Sulfate
13. Opera_id_1050
14. Schembl2837
15. Chembl1200780
16. Hms2230j04
17. Mfcd00133864
18. Akos025310614
19. 842t071
20. A923784
21. Tobramycin Sulfate Salt, Aminoglycoside Antibiotic
22. Q-201838
23. 2-ethoxy-5-[(morpholine-4-carbonyl)-amino]-benzenesulfonylchloride
24. (2s,3r,4s,5s,6r)-4-amino-2-(((1s,2s,3r,4s,6r)-4,6-diamino-3-(((2r,3r,5s,6r)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2h-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,5-diol Sulfate
25. (2s,3r,4s,5s,6r)-4-amino-2-((1s,2s,3r,4s,6r)-4,6-diamino-3-((2r,3r,5s,6r)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2h-pyran-2-yloxy)-2-hydroxycyclohexyloxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,5-diol Sulfate
26. (2s,3r,4s,5s,6r)-4-amino-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,5s,6r)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol,sulfuric Acid
| Molecular Weight | 565.6 g/mol |
|---|---|
| Molecular Formula | C18H39N5O13S |
| Hydrogen Bond Donor Count | 12 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 6 |
| Exact Mass | 565.22650749 g/mol |
| Monoisotopic Mass | 565.22650749 g/mol |
| Topological Polar Surface Area | 351 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 691 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 14 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 3 | |
|---|---|
| Drug Name | TOBRAMYCIN SULFATE |
| Active Ingredient | TOBRAMYCIN SULFATE |
| Company | AKORN (Application Number: A205179); BAXTER HLTHCARE CORP (Application Number: A206965); FRESENIUS KABI USA (Application Number: A065122); FRESENIUS KABI USA (Application Number: N050789); HOSPIRA (Application Number: A063111); HOSPIRA (Application Number: A063112); MYLAN LABS LTD (Application Number: A065407); TEVA PHARMS USA (Application Number: A063100); WEST-WARD PHARMS INT (Application Number: A063117); X GEN PHARMS (Application Number: A065013); XELLIA PHARMS APS (Application Number: A205685) |
| 2 of 3 | |
|---|---|
| Drug Name | TOBRAMYCIN SULFATE (PHARMACY BULK) |
| Active Ingredient | TOBRAMYCIN SULFATE |
| Company | FRESENIUS KABI USA (Application Number: A065120) |
| 3 of 3 | |
|---|---|
| Drug Name | TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER |
| Active Ingredient | TOBRAMYCIN SULFATE |
| Company | HOSPIRA (Application Number: A063081) |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Market Place
ABOUT THIS PAGE
A Nebicina manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nebicina, including repackagers and relabelers. The FDA regulates Nebicina manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nebicina API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nebicina supplier is an individual or a company that provides Nebicina active pharmaceutical ingredient (API) or Nebicina finished formulations upon request. The Nebicina suppliers may include Nebicina API manufacturers, exporters, distributors and traders.
Nebicina Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nebicina GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nebicina GMP manufacturer or Nebicina GMP API supplier for your needs.
A Nebicina CoA (Certificate of Analysis) is a formal document that attests to Nebicina's compliance with Nebicina specifications and serves as a tool for batch-level quality control.
Nebicina CoA mostly includes findings from lab analyses of a specific batch. For each Nebicina CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nebicina may be tested according to a variety of international standards, such as European Pharmacopoeia (Nebicina EP), Nebicina JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nebicina USP).
LOOKING FOR A SUPPLIER?
